Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.42 USD | +3.25% | +2.74% | +40.37% |
May. 31 | Piper Sandler Initiates Immunome With Overweight Rating, $27 Price Target | MT |
May. 21 | Immunome Insider Bought Shares Worth $1,388,072, According to a Recent SEC Filing | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
IMMUNOME, INC. | Bio Therapeutic Drugs | +1.94% | +2.74% | +40.37% | +191.09% | - | 896M |
Technical Rankings Surperformance
- Stock Market
- Equities
- IMNM Stock
- Charts Immunome, Inc.
- Comparison Chart